Codice QR

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

Objective To assess the efficacy of dalfampridine in patients with neuromyelitis optica spectrum disorder. Methods We included 15 consecutive patients, who were started on a treatment of dalfampridine 10 mg twice daily for 2 weeks. Efficacy assessment was based on walking ability improvement using T...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jérôme de Seze, Christine Clerc, Matthieu Béreau, Bertrand Bourre, Hélène Zephir, Nicolas Collongues, Laurent Kremer, Patrick Vermersch, Kevin Bigaut
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publishing 2024-01-01
Serie:Multiple Sclerosis Journal - Experimental, Translational and Clinical
Accesso online:https://doi.org/10.1177/20552173241233952
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!